BioCentury
ARTICLE | Company News

Netherlands approves Astellas' Vesomni

May 24, 2013 12:34 AM UTC

Astellas Pharma Inc. (Tokyo:4503) said the Netherlands Medicines Evaluation Board approved an MAA for Vesomni solifenacin/tamsulosin ( EC905) to treat moderate to severe storage symptoms and voiding s...